Deals
LabCorp Seen Luring Buyout Before Health-Care Revamp: Real M&A
This article is for subscribers only.
Laboratory Corp. of America Holdings is offering one of the biggest bargains to private-equity firms searching for health-care deals before a government-mandated overhaul adds millions of new customers.
The provider of medical tests trades for 11.8 times analysts’ 2013 earnings projections, the second-lowest level among U.S. health-care-services companies valued at more than $1 billion, according to data compiled by Bloomberg. On Aug. 1, its shares rallied the most since 2008 amid optimism a private-equity firm was considering a deal, and they have held most of that gain even after LabCorp said it wasn’t in discussions.